ES2036723T3 - Empleo de factor tumor-necrosis (inf) y linfotoxina (lt) en la fabricacion de medicamentos. - Google Patents

Empleo de factor tumor-necrosis (inf) y linfotoxina (lt) en la fabricacion de medicamentos.

Info

Publication number
ES2036723T3
ES2036723T3 ES198989100458T ES89100458T ES2036723T3 ES 2036723 T3 ES2036723 T3 ES 2036723T3 ES 198989100458 T ES198989100458 T ES 198989100458T ES 89100458 T ES89100458 T ES 89100458T ES 2036723 T3 ES2036723 T3 ES 2036723T3
Authority
ES
Spain
Prior art keywords
lymphotoxin
inf
medicines
tumor
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989100458T
Other languages
English (en)
Inventor
Erich Dr. Schlick
Manfred Dr. Kaufmann
Ulrich Dr. Raeth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Application granted granted Critical
Publication of ES2036723T3 publication Critical patent/ES2036723T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE DESCRIBE LA UTILIZACION DE TNF Y DE LT PARA PROFILAXIS Y TERAPIA DE DERRAMES EN CAVIDADES CORPORALES.
ES198989100458T 1988-01-15 1989-01-12 Empleo de factor tumor-necrosis (inf) y linfotoxina (lt) en la fabricacion de medicamentos. Expired - Lifetime ES2036723T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3801026 1988-01-15
DE3837012A DE3837012A1 (de) 1988-01-15 1988-10-31 Verwendung von tnf und lt zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
ES2036723T3 true ES2036723T3 (es) 1993-06-01

Family

ID=25863992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989100458T Expired - Lifetime ES2036723T3 (es) 1988-01-15 1989-01-12 Empleo de factor tumor-necrosis (inf) y linfotoxina (lt) en la fabricacion de medicamentos.

Country Status (9)

Country Link
US (2) US5133960A (es)
EP (1) EP0324464B1 (es)
JP (1) JPH01216938A (es)
AU (1) AU605013B2 (es)
CA (1) CA1329540C (es)
DE (2) DE3837012A1 (es)
DK (1) DK13989A (es)
ES (1) ES2036723T3 (es)
PT (1) PT89447B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
WO1997016169A1 (en) * 1995-11-01 1997-05-09 Chiron Corporation Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space
WO2002072788A2 (en) * 2001-03-14 2002-09-19 Centocor, Inc. Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75318A (en) * 1984-05-31 1994-08-26 Genentech Inc Recombinant human memotoxin and methods for its recombinant production
GR851626B (es) * 1984-07-05 1985-11-26 Genentech Inc
EP0200748B1 (en) * 1984-10-15 1991-02-06 Cetus Corporation Human tumor necrosis factor
EP0205038A1 (en) * 1985-05-29 1986-12-17 Suntory Limited Polypeptide, process for preparing it, microorganism and pharmaceutical use
JPS61280436A (ja) * 1986-06-12 1986-12-11 Dainippon Pharmaceut Co Ltd 利尿剤
DE3750056T2 (de) * 1986-06-20 1995-04-06 Dainippon Pharmaceutical Co Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
US4857314A (en) * 1986-07-18 1989-08-15 Health Research , Inc. C-reactive proteins in treatment of animal and human cancers

Also Published As

Publication number Publication date
DK13989D0 (da) 1989-01-13
EP0324464A2 (de) 1989-07-19
AU605013B2 (en) 1991-01-03
CA1329540C (en) 1994-05-17
EP0324464B1 (de) 1992-04-15
EP0324464A3 (en) 1990-01-31
DE3837012A1 (de) 1989-07-27
DK13989A (da) 1989-07-16
US5277903A (en) 1994-01-11
AU2847289A (en) 1989-07-20
JPH01216938A (ja) 1989-08-30
DE58901122D1 (de) 1992-05-21
US5133960A (en) 1992-07-28
PT89447B (pt) 1993-09-30
PT89447A (pt) 1990-02-08

Similar Documents

Publication Publication Date Title
BR8603954A (pt) Artigo absorvente
AU578428B2 (en) Trace-labeled conjugates of metallothionein and target- seeking biologically active molecules
DE3888064T2 (de) Niederfrequenz-Elektrotherapiegerät.
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
EP0349235A3 (en) Niacin-containing composition and its therapeutic use
IT8768027A0 (it) Derivati di 1 piperazinil pirimidina loro preparazione e impiego in terapia e cosmesi
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
FR2462167B1 (fr) Interferon de fibroplastes humains sous la forme d'une proteine homogene et sa preparation
IT8312019A0 (it) Mezzo di autotrattamento elettroterapeutico del dolore e dell'insonnia ad associazione di campi
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
ES2036723T3 (es) Empleo de factor tumor-necrosis (inf) y linfotoxina (lt) en la fabricacion de medicamentos.
FI941345A0 (fi) Retinoidit ja niiden käyttö ihosairauksien ja leukemian hoitoon
IT8220954A0 (it) Composti attivi nel trattamento dell'ulcera e di sintomi allergici della pelle
EP0437026A3 (en) Use of tandospirone in the treatment of depression
IT1206822B (it) Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
EP0280593A3 (en) Composition on the basis of an amino-acid and vitamins for use in cancer therapy
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
IT8323601A0 (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete.
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale
PH23711A (en) Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of inflammatory disease
FR2542197B1 (fr) Remede medicamenteux et prophylactique anticarie dentaire sous forme de granules
ES2060153T3 (es) Composicion terapeutica y cajita para el tratamiento de la poliartritis reumatoide.
IE882290L (en) Treatment of infections with tumor necrosis factor
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
GB8818567D0 (en) Tnf & formulations thereof in treatment/prophylaxis of hepatitis b

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 324464

Country of ref document: ES